These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Correction of the composition of the dialyzing solution during its electrochemical regeneration]. Maksimov EP; Leshchinskiĭ GM; Grinval'd VM; Fomicheva NN; Shadiev BSh Med Tekh; 2003; (2):8-10. PubMed ID: 12924213 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis]. Germin Petrović D Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391 [TBL] [Abstract][Full Text] [Related]
27. [The diffusion of diphenylhydantoin across the cellophane membrane of the artificial kidney in a patient with uremia and epilepsy]. Desjacques P Schweiz Rundsch Med Prax; 1972 Mar; 61(13):418-23. PubMed ID: 5020101 [No Abstract] [Full Text] [Related]
28. Boron diffusion across the dialysis membrane during hemodialysis. Usuda K; Kono K; Nishiura K; Miyata K; Nishiura H; Saito M; Goto E; Nakaya H Miner Electrolyte Metab; 1997; 23(2):100-4. PubMed ID: 9252976 [TBL] [Abstract][Full Text] [Related]
29. [Experience in using a small artificial kidney apparatus with regeneration and recirculation of the dialysing solution]. Sépp ON; Sutyko AD; Levitskiĭ ER Urol Nefrol (Mosk); 1978; (2):41-4. PubMed ID: 644720 [No Abstract] [Full Text] [Related]
30. Diurnal blood-pressure variations in haemodialysis and CAPD patients. Luik AJ; Struijk DG; Gladziwa U; von Olden RW; von Hooff JP; de Leeuw PW; Leunissen KM Nephrol Dial Transplant; 1994; 9(11):1616-21. PubMed ID: 7870351 [TBL] [Abstract][Full Text] [Related]
31. [Continuous hemodialysis with cuprophan membranes in critical patients]. Cotera A; Lorca E; Saffie A; Sepulveda M Rev Med Chil; 1994 Apr; 122(4):394-400. PubMed ID: 7809533 [TBL] [Abstract][Full Text] [Related]
32. Oxygen tension monitoring in uremic patients during hemodialysis treatment. Morosetti M; Meloni C; Mattia C; Meschini L; Corradini S; Rocco M; Taccone-Gallucci M; Casciani CU Artif Organs; 1990 Jun; 14(3):196-9. PubMed ID: 2357145 [TBL] [Abstract][Full Text] [Related]
34. [Relationship between the rates of blood and dialyzing solution flow and determination of the efficiency of the "artificial kidney" dialyzing apparatus]. Novozhilov IV; Kulakov GP; Balabanov AM; Tumkin SV Med Tekh; 1977; (2):26-31. PubMed ID: 881967 [TBL] [Abstract][Full Text] [Related]
35. Methods for increasing the efficiency of a new dialyzer-membrane oxygenator. Landé AJ; Parker B; Subramanian V; Carlson RG; Lillehei CW Trans Am Soc Artif Intern Organs; 1968; 14():227-32. PubMed ID: 5701535 [No Abstract] [Full Text] [Related]
36. [Acute changes in pulmonary diffusing capacity following hemodialysis treatment]. Reinhard U; Mikulla A Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():829-31. PubMed ID: 6647348 [No Abstract] [Full Text] [Related]
37. [Experimental model of peritoneal dialysis. II. Oxygen partial pressure and methemoglobin formation during dialysis of preserved blood in the cellophane membrane artificial kidney with PD375 and oxygen insufflation and with added hydrogen peroxide]. John H; Heine W Z Urol Nephrol; 1973 Dec; 66(12):929-32. PubMed ID: 4802071 [No Abstract] [Full Text] [Related]
38. Pentoxifylline does not prevent haemodialysis induced neutropaenia or hypoxaemia. Rayner BL; Pascoe MD; Thebus G Nephron; 1992; 60(3):363-5. PubMed ID: 1565191 [TBL] [Abstract][Full Text] [Related]
39. Fall in peak expiratory flow during haemodialysis in patients with chronic renal failure. Davenport A; Williams AJ Thorax; 1988 Sep; 43(9):693-6. PubMed ID: 3194875 [TBL] [Abstract][Full Text] [Related]